(Q26862596)

EMMA HOWIE

series ordinal

2

1 reference

DOROTHY TRUMP

series ordinal

3

1 reference

SUSAN M HUSON

series ordinal

4

1 reference

language of work or name

1 reference

February 2013

1 reference

Developmental Medicine and Child Neurology

published in

1 reference

volume

55

1 reference

issue

2

1 reference

page(s)

111-25

1 reference

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Psychological disturbance and sleep disorders in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Behavioral phenotype of neurofibromatosis, type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Cognitive profile of neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Cognitive deficits in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Brain structure and function in neurofibromatosis type 1: current concepts and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Neurofibromatosis type 1: new insights into neurocognitive issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Neurofibromatosis type 1: the cognitive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Impact of neurofibromatosis type 1 on school performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: nonverbal learning disabilities revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Cognitive profile of children with neurofibromatosis and reading disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Cortical morphology associated with language function in neurofibromatosis, type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

An examination of lexical and sublexical reading skills in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Functional magnetic resonance imaging of phonologic processing in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Functional MRI of visual-spatial processing in neurofibromatosis, type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Learning disability subtypes in children with neurofibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Visuospatial processing in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Visual-spatial performance deficits in children with neurofibromatosis type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Motor proficiency in children with neurofibromatosis type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Cognitive control in adolescents with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Motor learning in children with neurofibromatosis type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Positron emission tomography in children with neurofibromatosis-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

The handwriting performance of children with NF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Bone mineral density in children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Intellectual impairment in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Early grade repetition and inattention associated with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Treatment of ADHD in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Social skills of children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Social information processing in children and adolescents with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

The self-concept of children and adolescents with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

Mental, motor, and language development of toddlers with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

The cognitive profile of preschool-aged children with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-8749.2012.04399.X

10.1111/J.1469-8749.2012.04399.X

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

22934576

1 reference

Consolidated OpenCitations Corpus – April 2017